Reporting Calendar: Download here
Companies reporting today include: Adore Beauty (ABY), Altium (ALU), Crown Resorts (CWN), Fortescue (FMG), Healius (HLS), Invocare (IVC), Nuix (NXL), Temple & Webster (TPW)
Companies on MM’s radar include:
- Adore Beauty (ABY) FY21 Results: Expectations for revenue of $175.5m, EBITDA of $3.25m, NPAT of $2m, EPS of $0.018, No FY21 Dividend, Market currently pricing Revenue of $205m & EBITDA for FY22 of $8m, up ~145% on FY21. (MM Comment…ABY had guided to revenue growth of 43-47% and the market was in the middle at 45% ($175m), they’ve delivered $179m although no FY22 guidance provided. Overall, a beat in FY21, no guidance for FY22)
- Altium (ALU): FY21 Results: Expectations for revenue of $179m, EBITDA of $65.85m, NPAT of $46.35m (up ~50% on FY20), EPS of $0.327, FY21 Dividend of $0.33, Market currently pricing EBITDA for FY22 of $75.5m, up ~15% on FY21. (MM Comment…During the year ALU knocked back a takeover offer muted to be $40 a share by the end, so this result was import to show that management made the right call and the number + the rhetoric are optimistic. They met FY21 revenue guidance which the market was sceptical of, printing $191m up 1% on FY20 however importantly they have increased FY22 guidance, now expecting top line growth of 16-20%, the market was at 12%. Overall, beat + upgrade)
- Crown Resorts (CWN) FY21 Results: Expectations for revenue of $1.48b, EBITDA of $247m, Pre-tax loss of $105m (versus NPAT of $152.9m in FY20), EPS of -$0.12, FY21 Dividend of $0.044. Market currently pricing NPAT for FY22 of $135m, up from a loss in FY21. (MM Comment…)
- Fortescue (FMG) FY21 Results ($US): Expectations for revenue of $22.12b, NPAT of $10.1b (up ~100% on FY20), EPS of $3.285, FY21 Dividend of A$3.518. Market currently pricing NPAT for FY22 of $8.8b, down ~12% on FY21. (MM Comment…FMG posted FY21 NPAT of $10.3bn up nearly 120% YoY and a dividend of A$3.58 which was inline, a huge result, hard to fault this financial scorecard from FMG. Operationally very strong, the Iron Ore price now the key. Overall, inline
- Healius (HLS) FY21 Results: Expectations for revenue of $1.93b, EBITDA of $511m, NPAT of $150m (up ~170% on FY20), EPS of $0.242, FY21 Dividend of $0.133. Market currently pricing NPAT for FY22 of $136.5m, up ~9% on FY21. (MM Comment…)
- Invocare (IVC) FY21 Results: Expectations for revenue of $522m, EBITDA of $126m, NPAT of $40m (up ~46% on FY20), EPS of $0.277, FY21 Dividend of $0.23. Market currently pricing NPAT for FY22 of $53.68m, up ~34% on FY21. (MM Comment…)
- Nuix (NXL) FY21 Results: Only Morgan Stanley covers it and they have revenue of $178m, EBITDA of $65.5m & & NPAT of $21.8m pricing in revenue growth of ~20% in FY22.
- Temple & Webster (TPW) Expectations for revenue of $325m & EBITDA of $20.6m. Market currently pricing Revenue of $427m & EBITDA for FY22 of $13.9m, down ~40% on FY21. (MM Comment…TPW have delivered revenue & EBITDA inline with expectations and very strong on FY20. Commentary around AI very interesting, this is a presentation worth a read in terms of online retail. No specific guidance however they say trading has started well up to end of August, with sales up +49% which is ahead of the growth rate the market is assuming for the FY. Overall, inline with a good trading update).
- Lend Lease (LLC): Strategy update today
NB: Results will be covered on the MM Website throughout the day: Visit www.marketmatters.com.au
